We are live on ! Find out more
CIBC Private Wealth Group

CIBC Private Wealth Group Portfolio holdings

AUM $59.2B
1-Year Est. Return 20.62%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+20.62%
3 Year Est. Return
+88.19%
5 Year Est. Return
+111.32%
10 Year Est. Return
+389.71%
AUM
$28.5B
AUM Growth
+$2.58B
Cap. Flow
+$1.54B
Cap. Flow %
5.41%
Top 10 Hldgs %
21.33%
Holding
985
New
63
Increased
321
Reduced
431
Closed
71

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$86.6M
2
AMZN icon
Amazon
AMZN
+$83.2M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$83M
4
MSFT icon
Microsoft
MSFT
+$73.2M
5
V icon
Visa
V
+$61.7M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$94.5M
2
BX icon
Blackstone
BX
+$66.8M
3
ELV icon
Elevance Health
ELV
+$64M
4
WDAY icon
Workday
WDAY
+$61.3M
5
SSNC icon
SS&C Technologies
SSNC
+$54M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Healthcare 13.66%
3 Financials 13.6%
4 Energy 13.45%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRMD icon
901
CorMedix
CRMD
$617M
$108K ﹤0.01%
+12,000
New +$94.2K
DVAX
902
DELISTED
Dynavax Technologies
DVAX
$90K ﹤0.01%
22,500
WATT icon
903
Energous
WATT
$80.3M
$87K ﹤0.01%
33
+3
+10% +$8.76K
BCLI
904
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$69K ﹤0.01%
1,166
-3,333
-74% -$194K
SNT
905
Senstar Technologies
SNT
$41.1M
$50K ﹤0.01%
10,000
VUZI icon
906
Vuzix
VUZI
$190M
$41K ﹤0.01%
10,000
AREC icon
907
American Resources Corp
AREC
$186M
$30K ﹤0.01%
10,040
PLM
908
DELISTED
PolyMet Mining Corp.
PLM
$21K ﹤0.01%
4,910
DMK
909
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$20K ﹤0.01%
214
NEOS
910
DELISTED
Neos Therapeutics, Inc
NEOS
$20K ﹤0.01%
15,335
PLX icon
911
Protalix BioTherapeutics
PLX
$191M
$12K ﹤0.01%
2,500
TYME
912
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$12K ﹤0.01%
10,000
AVEO
913
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$8K ﹤0.01%
+1,200
New +$10.3K
GMO
914
DELISTED
General Moly, Inc.
GMO
$5K ﹤0.01%
13,518
ACHC icon
915
Acadia Healthcare
ACHC
$3.17B
-30,759
Closed -$902K
ACWX icon
916
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
-10,373
Closed -$480K
AGO icon
917
Assured Guaranty
AGO
$3.78B
-11,860
Closed -$527K
AR icon
918
Antero Resources
AR
$10.9B
-500,174
Closed -$4.42M
ATKR icon
919
Atkore
ATKR
$2.59B
-15,150
Closed -$326K
BB icon
920
BlackBerry
BB
$5.01B
-50,409
Closed -$508K
BOTZ icon
921
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.15B
-12,455
Closed -$250K
CC icon
922
Chemours
CC
$2.59B
-36,886
Closed -$1.37M
CGBD icon
923
Carlyle Secured Lending
CGBD
$698M
-103,044
Closed -$1.49M
CIGI icon
924
Colliers International
CIGI
$4.98B
-4,827
Closed -$322K
COLM icon
925
Columbia Sportswear
COLM
$3.19B
-3,238
Closed -$337K

Similar funds

CIBC Private Wealth Group's Q2 2019 Portfolio in Review

As of Q2 2019, CIBC Private Wealth Group held 985 positions worth $28.5B, up 9.9% from $25.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

CIBC Private Wealth Group deployed $1.54B of net new capital in Q2 2019, opening 63 new positions and adding to 321 existing holdings. Its largest new stake was Dow Inc: 903,285 shares worth $44.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $94.5M trimmed.

  • CIBC Private Wealth Group's largest Q2 2019 buy was Dow Inc: 903,285 shares worth $44.5M.
  • CIBC Private Wealth Group added most to Charles Schwab in Q2 2019, an estimated $86.6M increase.
  • CIBC Private Wealth Group's biggest Q2 2019 reduction was CVS Health, cutting an estimated $94.5M.
  • CIBC Private Wealth Group fully exited Bemis in Q2 2019, selling an estimated $9.65M.
  • CIBC Private Wealth Group's ten largest holdings make up 21% of its $28.5B portfolio in Q2 2019.
  • CIBC Private Wealth Group opened 63 new positions and closed 71 in Q2 2019.
  • CIBC Private Wealth Group's portfolio value rose 9.9% quarter-over-quarter to $28.5B.

Based on CIBC Private Wealth Group's 13F filing for Q2 2019, filed 31 Jul 2019.